Telix Pharmaceuticals Ltd (TLPPF) Stock Price & News

All values in USD	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	195.18M	195.18M	206.72M	206.72M
Cost of goods sold	100.29M	100.29M	110.68M	110.68M
Cost of revenue	100.29M	100.29M	110.68M	110.68M
Research and development expenses	40.79M	40.79M	44.83M	44.83M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	48.35M	48.35M	47.93M	47.93M
Operating expense	89.26M	89.26M	92.02M	92.02M
Total operating expenses	189.55M	189.55M	202.70M	202.70M
Operating income	5.62M	5.62M	4.02M	4.02M
Other non operating income	-6.32M	-6.32M	-7.23M	-7.23M
EBT including unusual items	-2.42M	-2.42M	-215.00K	-215.00K
EBT excluding unusual items	-1.41M	-1.41M	-6.75M	-6.75M
Income tax expense	-1.27M	-1.27M	2.20M	2.20M
Effective tax rate	52.61%	52.61%	-1,023.95%	-1,023.95%
Other operating expenses	122.50K	122.50K	-745.50K	-745.50K
Net income	-1.15M	-1.15M	-2.42M	-2.42M
Net profit margin	-0.59%	-0.59%	-1.17%	-1.17%
Earnings per share	-	-	-	-
Interest and investment income	1.81M	1.81M	1.10M	1.10M
Interest expense	-3.10M	-3.10M	-3.78M	-3.78M
Net interest expenses	-1.29M	-1.29M	-2.68M	-2.68M
Depreciation and amortization charges	-	-	-	-
EBITDA	9.14M	9.14M	7.09M	7.09M
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance